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Di-macrocyclic terephthalamide ligand (1).
Benzyl and tert-butyloxycarbonyl-protected dimacrocycle 9 (10 mg, 4.4 µmol) was dissolved in 12 N hydrochloric acid (0.5 mL, BDH Aristar Plus) and glacial acetic acid (0.5 mL, 99.99+%). The solution was stirred under inert atmosphere for 44 hr, whereupon HCl was removed with a stream of inert gas. Solvents were removed under reduced pressure and the residue was dried in vacuo. The residue was dissolved in methanol (2 x 200 µL) and transferred to an O-ring microcentrifuge tube. Ether (ca. 1.5 mL) was added, and the tube was placed at 4 o C overnight. The tube was centrifuged at 12,000 rpm for 3 minutes, decanted; the pellet was washed with ether (ca. 1.5 mL) and allowed to air dry. The pellet was dried in vacuo to provide di-macrocycle 1, pentahydrochloride salt (6.75 mg, 94% Zr-ligand complex remained at the origin (Fig. S6 ). The identity of each radioactive complex was further confirmed by comparing its radio-HPLC elution profile to the UV-HPLC spectrum of its nonradioactive In vitro serum stability and DTPA challenge study. In vitro stability was carried out by adding 10 µL of each 89 Zr-labeled complex (50 μCi, 1.85 MBq) to 500 µL DTPA (50 mM, pH7), or human serum. The solutions (n=12) were incubated at 37 °C for 7 days and were analyzed daily for 1 week by radio-TLC using Varian ITLC-SG strips and 50 mM DTPA (pH 7) as the mobile phase and gamma counting using an energy window of 500-1500 keV and standard protocols. MBq) to a mixture of 500 μL of octanol and 500 μL of water. 6 The resulting solutions (n = 4) were vigorously vortexed for 5 min at room temperature, then centrifuged for 5 min to ensure complete separation of layers. From each of the four sets, 50 μL aliquot was removed from each phase into screw tubes and counted separately in a gamma counter. Each organic phase was washed with water to remove any radioactivity remaining in the organic phase before gamma counting. The partition coefficient was calculated as a ratio of counts in the octanol fraction to counts in the water fraction. The logP values were reported in an average of four measurements.
Biodistribution Studies. Biodistribution studies were conducted using a modified literature procedure. 7 Briefly, female NIH Swiss mice (6-8 wk old, n=6) Zr-DFO in selected organs at 2, 4, 24, 48, and 72 h p.i.
